The histaminergic system in human thalamus: correlation of innervation to receptor expression.
The mRNA expression of three histamine receptors (H1, H2 and H3) and H1 and H3 receptor binding were mapped and quantified in normal human thalamus by in situ hybridization and receptor binding autoradiography, respectively. Immunohistochemistry was applied to study the distribution of histaminergic fibres and terminals in the normal human thalamus. mRNAs for all three histamine receptors were detected mainly in the dorsal thalamus, but the expression intensities were different. Briefly, H1 and H3 receptor mRNAs were relatively enriched in the anterior, medial, and part of the lateral nuclei regions; whereas the expression level was much lower in the ventral and posterior parts of the thalamus, and the reticular nucleus. H2 receptor mRNA displayed in general very low expression intensity with slightly higher expression level in the anterior and lateropolar regions. H1 receptor binding was mainly detected in the mediodorsal, ventroposterolateral nuclei, and the pulvinar. H3 receptor binding was detected mainly in the dorsal thalamus, predominantly the periventricular, mediodorsal, and posterior regions. Very high or high histaminergic fibre densities were observed in the midline nuclear region and other nuclei next to the third ventricle, ventroposterior lateral nucleus and medial geniculate nucleus. In most of the core structures of the thalamus, the fibre density was very low or absent. The results suggest that histamine in human brain regulates tactile and proprioceptory thalamocortical functions through multiple receptors. Also, other, e.g. visual areas and those not making cortical connections expressed histamine receptors and contained histaminergic nerve fibres.
Jin
C Y
CY
Department of Biology, Abo Akademi University, BioCity, Tykistokatu 6A, FIN-20520 Turku, Finland.
Kalimo
H
H
Panula
Pertti
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D015870:Gene Expression / Q000502:physiology; D006632:Histamine / Q000378:metabolism*; D018494:Histamine Agents; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D017729:Presynaptic Terminals / Q000378:metabolism* / Q000648:ultrastructure; D012333:RNA, Messenger / Q000378:metabolism*; D011869:Radioligand Assay; D011968:Receptors, Histamine / Q000235:genetics*; D011969:Receptors, Histamine H1 / Q000235:genetics; D011970:Receptors, Histamine H2 / Q000235:genetics; D018100:Receptors, Histamine H3 / Q000235:genetics; D009435:Synaptic Transmission / Q000502:physiology*; D013788:Thalamus / Q000166:cytology / Q000378:metabolism*
D018494:Histamine Agents; D012333:RNA, Messenger; D011968:Receptors, Histamine; D011969:Receptors, Histamine H1; D011970:Receptors, Histamine H2; D018100:Receptors, Histamine H3; D006632:Histamine